Skip to main content

Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders Workshop Summary (2015) / Chapter Skim
Currently Skimming:

Appendix A: References
Pages 61-64

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 61...
... 2010. Trends in risks associated with new drug development: Success rates for investigational drugs.
Read the entire page →
From page 62...
... Paper presented at the European Medicines Agency Workshop for Micro, Small and Medium Sized Enterprises, London, UK, April 26. Grabowski, H., G
Read the entire page →
From page 63...
... 2013. Advisory committee to the NIH Director interim report: Brain research through advancing innovative neurotechnologies (brain)
Read the entire page →
From page 64...
... 2015a. 21st Century Cures Act discussion document.
Read the entire page →

Key Terms

  • nature reviews
  • drug development
  • drug discovery
  • brain research
  • national multiple

  • multiple sclerosis
  • century cures
  • discussion document
  • accessed june
  • workshop summary

  • sclerosis society
  • venture funding
  • frequently asked
  • pharmaceutical patent
  • paediatric rewards

  • design clinical
  • cures act
  • major drug
  • psychiatric drug
  • medicines agency

  • cns drug
  • industry organization
  • global economic
  • clinical trials
  • breakthrough cns

  • cures discussion
  • tufts center
  • minimizing risk
  • comprehensive look
  • shut brain


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.